BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26269603)

  • 1. Improvement of Stability and Efficacy of C16Y Therapeutic Peptide via Molecular Self-Assembly into Tumor-Responsive Nanoformulation.
    Ding Y; Ji T; Zhao Y; Zhang Y; Zhao X; Zhao R; Lang J; Zhao X; Shi J; Sukumar S; Nie G
    Mol Cancer Ther; 2015 Oct; 14(10):2390-400. PubMed ID: 26269603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy.
    Cheng K; Ding Y; Zhao Y; Ye S; Zhao X; Zhang Y; Ji T; Wu H; Wang B; Anderson GJ; Ren L; Nie G
    Nano Lett; 2018 May; 18(5):3250-3258. PubMed ID: 29683683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Screening System for Targeting Carriers Using Peptide-Modified Liposomes and Tissue Sections.
    Negishi Y; Hamano N; Sato H; Katagiri F; Takatori K; Endo-Takahashi Y; Kikkawa Y; Nomizu M
    Biol Pharm Bull; 2018; 41(7):1107-1111. PubMed ID: 29962407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
    Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
    Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.
    Cao M; Lu S; Wang N; Xu H; Cox H; Li R; Waigh T; Han Y; Wang Y; Lu JR
    ACS Appl Mater Interfaces; 2019 May; 11(18):16357-16366. PubMed ID: 30991000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
    Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
    ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy.
    Liang P; Zheng J; Dai S; Wang J; Zhang Z; Kang T; Quan C
    J Control Release; 2017 Aug; 260():22-31. PubMed ID: 28522193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperatively Responsive Peptide Nanotherapeutic that Regulates Angiopoietin Receptor Tie2 Activity in Tumor Microenvironment To Prevent Breast Tumor Relapse after Chemotherapy.
    Zhang L; Qi Y; Min H; Ni C; Wang F; Wang B; Qin H; Zhang Y; Liu G; Qin Y; Duan X; Li F; Han X; Tao N; Zhang L; Qin Z; Zhao Y; Nie G
    ACS Nano; 2019 May; 13(5):5091-5102. PubMed ID: 30986342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug.
    Jiang X; Fan X; Xu W; Zhao C; Wu H; Zhang R; Wu G
    J Control Release; 2019 Dec; 316():196-207. PubMed ID: 31682910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
    Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
    J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
    Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN
    Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug.
    Mei L; Liu Y; Zhang H; Zhang Z; Gao H; He Q
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9577-89. PubMed ID: 27058058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.
    Xu C; Sun Y; Yu Y; Hu M; Yang C; Zhang Z
    Nanoscale; 2019 Jan; 11(3):1177-1194. PubMed ID: 30601512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.